Clinical Trial Update: Dose-finding Study of KHK7791 in Hyperphosphatemia Patients [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of KHK7791 for hyperphosphatemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• KHK7791

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Hyperphosphatemia | Phase 2 | Status: COMPLETED